Eledon Pharmaceuticals Inc. buy Maxi_Scalibusa
Start price
23.01.21
/
50%
€13.36
Target price
23.01.22
€100.00
Performance (%)
-77.10%
End price
24.01.22
€3.06
Summary
This prediction ended on 24.01.22 with a price of €3.06. Massive losses of -77.10% were the result for the BUY prediction by Maxi_Scalibusa. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eledon Pharmaceuticals Inc. | 3.846% | 3.846% | -67.073% | -40.265% |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% | 47.267% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% | 68.687% |
According to Maxi_Scalibusa what are the pros and cons of Eledon Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Novus Therapeutics Inc. diskutieren
In the thread Trading Novus Therapeutics Inc.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten